GSK plc announced with effect from 11 March 2024, Dr. Hal Dietz has been appointed a member of the Nominations & Corporate Governance Committee. This appointment is in addition to his role as Chair of the Science Committee and membership of the Chairs' Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,604 GBX | -0.34% | -1.50% | +10.64% |
Jun. 13 | REGENXBIO Inc. Announces Chief Executive Officer Changes | CI |
Jun. 12 | Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.64% | 82.98B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK plc Appoints Hal Dietz as Member of Nominations & Corporate Governance Committee, Effective 11 March 2024